GLUCAGON ADMINISTRATION DECREASES HEPATIC NUCLEAR TRIIODOTHYRONINE BINDING CAPACITY

Wolfgang Dillmann, Robert A. Bonner, Jack H. Oppenheimer

Endocrinology · 1978 · 47 citations · 14 references

Concepts

Abstract

The maximal binding capacity (MBC) of nuclear triiodothyronine (T3) receptor sites in rat liver decreases markedly after glucagon administration. Administration of serial doses of glucagon (2.5 microgram/100 g BW) resulted in a 33% decrease in MBC in 3.5 h and MBC was reduced by 45% in 6.25 h. The individual doses used were in the same order of magnitude as those used in the treatment of hypoglycemic human subjects (1.5 microgram/100 g BW). This report presents the first evidence that a peptide hormone can change the number of nuclear T3 receptor sites. The physiological significance of these findings remains to be clarified.

References

14